Session 3: New Drug Update - Part II

Date: 4/27/2012 Check-In and Breakfast:
 7:00 am - 7:30 am
Educational Session: 7:30 am - 1:00 pm

C. Wayne Weart,Pharm.D., FASHP,FAPhA, BCPS
Professor of Family Medicine, MUSC College of Medicine
Professor of Clinical Pharmacy and Outcome Sciences,
South Carolina College of Pharmacy, MUSC Campus.

Dr. Weart is on the speakers bureau for Novartis, in the area of hypertension and Pfizer in the areas of cardiovascular disease and pain. He is a consultant for Merck in the area of outcomes research.

At the conclusion of this presentation, the participant should be able to:

Objectives:

  • Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms , and MedWatch alerts.
  • Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
  • Describe their adverse effects and drug interactions that may affect patient compliance.
  • Compare efficacy, dosage and cost to existing agent.
  • Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.